Scott R Evans

Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial

Yongjun Wang, Mikael Knutsson, Gregory W Albers, 2020, Clinical trials.

Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes

Toshimitsu Hamasaki, Tomoyuki Sugimoto, Susan Halabi, 2019, Lifetime data analysis.

Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.

Robert A Bonomo, Scott R Evans, Robin Patel, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes

Toshimitsu Hamasaki, Takashi Sozu, Tomoyuki Sugimoto, 2015, Statistics in biopharmaceutical research.

Fundamentals of clinical trial design.

Scott R Evans, S. Evans, 2010, Journal of experimental stroke & translational medicine.

Sample size determination in group‐sequential clinical trials with two co‐primary endpoints

Kenichi Hayashi, Toshimitsu Hamasaki, Takashi Sozu, 2014, Statistics in medicine.

Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME).

Liang Chen, Kristine M Hujer, Robert A Bonomo, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sample Size Considerations in Clinical Trials When Comparing Two Interventions Using Multiple Co-Primary Binary Relative Risk Contrasts

Yuko Ohno, Yuki Ando, Toshimitsu Hamasaki, 2015, Statistics in biopharmaceutical research.

Sizing clinical trials when comparing bivariate time‐to‐event outcomes

Toshimitsu Hamasaki, Takashi Sozu, Tomoyuki Sugimoto, 2017, Statistics in medicine.

Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.

Federico Perez, Liang Chen, Kristine M Hujer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints.

Toshimitsu Hamasaki, Takashi Sozu, Tomoyuki Sugimoto, 2013, Biostatistics.

Antibacterial resistance leadership group: open for business.

Brad Spellberg, Robert A Bonomo, Vance G Fowler, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.